This investment was made when British International Investment was named CDC Group.
Saham Pharma is a pharmaceutical production and distribution company based in Morocco. It specialises in the production of antibiotics for the general public and the distribution of niche products for the hospital sector (plasma factors for treating hemophilia, chemotherapy supplements, painkillers). Saham Pharma is one of the main suppliers of antibiotics and specialty drugs in Morocco.
Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.
- Africa, North Africa
We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people.
- Investment type
We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).
- Intermediated investment
- SPE Capital Africa Industrialisation Fund
- Fund Manager:
- SPE Capital
- Start date
For direct investments, this is the date British International Investment committed capital to the business or project.
For funds, this is the date that British International Investment committed capital to the fund.
For underlying fund investments, this is the date that the fund invested capital into the business.e
- March 2020
This is the investee company’s place of incorporation; or a fund’s jurisdiction.